Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Cancer|December 19, 2014
The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancerConor E Steuer, Fadlo R Khuri, Suresh S RamalingamCancer|November 18, 2024
Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low-income countriesArafat H Tfayli, Laura N El-Halabi, Fadlo R KhuriCancer|February 2, 2012
Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trialsRebecca D Pentz, Margaret White, R Donald Harvey, et al.Cancer|November 13, 2004
Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignanciesKim-Anh Do, Marcella M Johnson, J Jack Lee, et al.Cancer|September 30, 2017
Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literatureRathi N Pillai, Madhusmita Behera, Taofeek K Owonikoko, et al.Cancer|March 26, 2014
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancerHyunseok Kang, Theresa W Gillespie, Michael Goodman, et al.Cancer|July 26, 2017
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation ConsortiumRathi N Pillai, Madhusmita Behera, Lynne D Berry, et al.Cancer|January 24, 2013
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancerTaofeek K Owonikoko, Mohammad S Hossain, Chandar Bhimani, et al.Cancer|February 26, 2004
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N statusFaye M Johnson, Adam Garden, J Lynn Palmer, et al.Cancer|July 22, 2015
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinomaGuoqing Qian, Ning Jiang, Dongsheng Wang, et al.Pageof 3